Brendan Teehan

EVP, COO, HEAD OF COMMERCIAL

Brendan Teehan (EVP, COO, HEAD OF COMMERCIAL) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in ACADIA Pharmaceuticals Inc. (ACAD). The largest single filing was $174K of ACAD (10,329 sh × $16.81, as filed), executed Nov 19 2024.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$174K

shares × price, as filed

Last traded

Nov 19 2024

Filed Nov 19 2024

Median ADV $49.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $174K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 24 months

Most traded names

ACAD

ACADIA Pharmaceuticals Inc. ACAD · 0 buys · 1 sell 1 filing

Recent filings

ACADSALE ACADIA Pharmaceuticals Inc. View filing → $174K
10,329 sh × $16.81
Exec Nov 19 2024
Filed Nov 19 2024 · 5:30 PM ET